These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8941602)

  • 21. Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer.
    Grob CS; Danforth AL; Chopra GS; Hagerty M; McKay CR; Halberstadt AL; Greer GR
    Arch Gen Psychiatry; 2011 Jan; 68(1):71-8. PubMed ID: 20819978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies.
    Studerus E; Kometer M; Hasler F; Vollenweider FX
    J Psychopharmacol; 2011 Nov; 25(11):1434-52. PubMed ID: 20855349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psilocybin-induced takotsubo cardiomyopathy.
    Kotts WJ; Gamble DT; Dawson DK; Connor D
    BMJ Case Rep; 2022 May; 15(5):. PubMed ID: 35580942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psilocybin: Good Trip or Bad Trip.
    Sellers EM
    Clin Pharmacol Ther; 2017 Oct; 102(4):580-584. PubMed ID: 28548221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The rising price of mushrooms.
    Young RE; Milroy R; Hutchison S; Kesson CM
    Lancet; 1982 Jan; 1(8265):213-5. PubMed ID: 6119567
    [No Abstract]   [Full Text] [Related]  

  • 26. Hallucinogens as medicine.
    Griffths RR; Grob CS
    Sci Am; 2010 Dec; 303(6):76-9. PubMed ID: 21141361
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of the hallucinogen psilocybin on covert orienting of visual attention in humans.
    Gouzoulis-Mayfrank E; Thelen B; Maier S; Heekeren K; Kovar KA; Sass H; Spitzer M
    Neuropsychobiology; 2002; 45(4):205-12. PubMed ID: 12097810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Presence of phenylethylamine in hallucinogenic Psilocybe mushroom: possible role in adverse reactions.
    Beck O; Helander A; Karlson-Stiber C; Stephansson N
    J Anal Toxicol; 1998; 22(1):45-9. PubMed ID: 9491968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hallucinogenic mushrooms in Mississippi.
    Jacobs KW
    J Miss State Med Assoc; 1975 Feb; 16(2):35-7. PubMed ID: 1089159
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hallucinogenic psilocybine containing mushrooms. Toxins contained in Danish wild mushrooms].
    Lassen JF; Ravn HB; Lassen SF
    Ugeskr Laeger; 1990 Jan; 152(5):314-7. PubMed ID: 2301080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hallucinogenic mushrooms].
    Reingardiene D; Vilcinskaite J; Lazauskas R
    Medicina (Kaunas); 2005; 41(12):1067-70. PubMed ID: 16401965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA-based taxonomic identification of basidiospores in hallucinogenic mushrooms cultivated in "grow-kits" seized by the police: LC-UV quali-quantitative determination of psilocybin and psilocin.
    Gambaro V; Roda G; Visconti GL; Arnoldi S; Casagni E; Dell'Acqua L; Farè F; Paladino E; Rusconi C; Arioli S; Mora D
    J Pharm Biomed Anal; 2016 Jun; 125():427-32. PubMed ID: 27021629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study.
    Bogenschutz MP; Forcehimes AA; Pommy JA; Wilcox CE; Barbosa PC; Strassman RJ
    J Psychopharmacol; 2015 Mar; 29(3):289-99. PubMed ID: 25586396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psilocybin intoxication.
    Dewhurst K
    Br J Psychiatry; 1980 Sep; 137():303-4. PubMed ID: 7192167
    [No Abstract]   [Full Text] [Related]  

  • 35. Analysis of psilocybin and psilocin in mushroom extracts by reversed-phase high performance liquid chromatography.
    Thomson BM
    J Forensic Sci; 1980 Oct; 25(4):779-85. PubMed ID: 7191888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dimethyltryptamine (DMT): prevalence, user characteristics and abuse liability in a large global sample.
    Winstock AR; Kaar S; Borschmann R
    J Psychopharmacol; 2014 Jan; 28(1):49-54. PubMed ID: 24284475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Not imagining it. Research into hallucinogens cautiously resumes.
    Biello D
    Sci Am; 2006 Nov; 295(5):33-5. PubMed ID: 17076078
    [No Abstract]   [Full Text] [Related]  

  • 38. Dependence on LSD and other hallucinogenic drugs.
    JAMA; 1967 Oct; 202(1):141-4. PubMed ID: 6072003
    [No Abstract]   [Full Text] [Related]  

  • 39. Injury-Triggered Blueing Reactions of Psilocybe "Magic" Mushrooms.
    Lenz C; Wick J; Braga D; García-Altares M; Lackner G; Hertweck C; Gressler M; Hoffmeister D
    Angew Chem Int Ed Engl; 2020 Jan; 59(4):1450-1454. PubMed ID: 31725937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers.
    Kraehenmann R; Preller KH; Scheidegger M; Pokorny T; Bosch OG; Seifritz E; Vollenweider FX
    Biol Psychiatry; 2015 Oct; 78(8):572-81. PubMed ID: 24882567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.